IgE and respiratory disease;Immunoglobuline E et maladies respiratoires

Revue des Maladies Respiratoires

Volumn 22, Issue 6, 2005, Pages 967-981

  Girodet, P O ^a   Casset, A ^b   Magnan, A ^c   De Blay, F ^b   Chanez, P ^d   Tunon De Lara, J M ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

Allergy; Asthma; Atopy; Immunotherapy

Indexed keywords

CD23 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR;

AIRWAY; ANTIGEN PRESENTATION; ASTHMA; ATOPY; BASOPHIL; BRONCHOPULMONARY ASPERGILLOMA; BRONCHUS HYPERREACTIVITY; CELL DIFFERENTIATION; HUMAN; IMMUNOTHERAPY; INFLAMMATORY CELL; MAST CELL; RESPIRATORY TRACT DISEASE; REVIEW; SYMPTOMATOLOGY; TH2 CELL;

EID: 33244478958     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1019/200530112     Document Type: Review

References (139)

1. Bennich HH, Ishizaka K, Johansson SG, Rowe DS, Stanworth DR, Terry WD : Immunoglobulin E: a new class of human immunoglobulin. Immunology 1968 ; 15 : 323-4.
2. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG : Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989 ; 320 : 271-7.
3. Sutton BJ, Gould HJ : The human IgE network. Nature 1993 ; 366 : 421-8.
4. Garman SC, Wurzburg BA, Tarchevskaya SS, Kiner JP, Jardetzky TS : Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilonRI alpha. Nature 2000 ; 406 : 259-66.
5. Shi J, Ghirlando R, Beavil RL, Beavil AJ, Keown MB, Young RJ, Owens RJ, Sutton BJ, Gould HJ : Interaction of the low-affinity receptor CD23/Fc epsilonRII lectin domain with the Fc epsilon3-4 fragment of human immunoglobulin E. Biochemistry 1997 ; 36 : 2112-22.
6. Presta L, Shields R, O'Connell L, Lahr S, Porter J, Gorman C, Jardieu P : The binding site on human immunoglobulin E for its high affinity receptor. J Biol Chem 1994 ; 269 : 26368-73.
7. Prussin C, Metcalfe DD : 4. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2003 ; 111 : S486-94.
8. Vercelli D : The regulation of IgE synthesis. Clin Allergy Immunol 2002 ; 16 : 179-96.
9. Oettgen HC, Geha RS : IgE regulation and roles in asthma pathogenesis. J Allergy Clin Immunol 2001 ; 107 : 429-40.
10. Kuhn R, Rajewsky K, Muller W : Generation and analysis of interleukin-4 deficient mice. Science 1991 ; 254 : 707-10.
11. Punnonen J, Aversa G, Cocks BG, McKenzie AN, Menon S, Zurawski G, de Waal Malefyt R, de Vries JE : Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A 1993 ; 90 : 3730-4.
12. Zurawski G, de Vries JE : Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994; 15 : 19-26.
13. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD : Interleukin-13: central mediator of allergic asthma. Science 1998 ; 282 : 2258-61.
14. Vercelli D, Jabara HH, Arai K, Geha RS : Induction of human IgE synthesis requires interleukin 4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens. J Exp Med 1989 ; 169: 1295-307.
15. Aubry JP, Pochon S, Graber P, Jansen KU, Bonnefoy JY : CD21 is a ligand for CD23 and regulates IgE production. Nature 1992 ; 358 : 505-7.
16. Sandford AJ, Shirakawa T, Moffatt MF, Daniels SE, Ra C, Faux JA, Young RP, Nakamura Y, Lathrop GM, Cookson WO, Hopkin JM : Localisation of atopy and beta subunit of high-affinity IgE receptor (Fc epsilon RI) on chromosome 11q. Lancet 1993 ; 341 : 332-4.
17. Maurer D, Ebner C, Reininger B, Fiebiger E, Kraft D, Kinet JP, Stingl G : The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J Immunol 1995 ; 154 : 6285-90.
18. Saini SS, Klion AD, Holland SM, Hamilton RG, Bochner BS, Macglashan DW Jr : The relationship between serum IgE and surface levels of FcepsilonR on human leukocytes in various diseases: correlation of expression with FcepsilonRI on basophils but not on monocytes or eosinophils. J Allergy Clin Immunol 2000 ; 106 : 514-20.
19. Bieber T : Fc epsilon RI on human Langerhans cells: a receptor in search of new functions. Immunol Today 1994 ; 15 : 52-3.
20. Tunon-De-Lara JM, Redington AE, Bradding P, Church MK, Hartley JA, Semper AE, Holgate ST : Dendritic cells in normal and asthmatic airways: expression of the alpha subunit of the high affinity immunoglobulin E receptor (Fc epsilon RI -alpha). Clin Exp Allergy 1996 ; 26 : 648-55.
21. Gounni AS, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, Capron A, Kinet JP, Capron M : High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 1994 ; 367 : 183-6.
22. Rajakulasingam K, Till S, Ying S, Humbert M, Barkans J, Sullivan M, Meng Q, Corrigan CJ, Bungre J, Grant JA, Kay AB, Durham SR: Increased expression of high affinity IgE (FcepsilonRI) receptor-alpha chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthma. Am J Respir Crit Care Med 1998 ; 158 : 233-40.
23. Benhamou M, Gutkind JS, Robbins KC, Siraganian RP : Tyrosine phosphorylation coupled to IgE receptor-mediated signal transduction and histamine release. Proc Natl Acad Sci USA 1990 ; 87 : 5327-30.
24. Benhamou M, Stephan V, Robbins KC, Siraganian RP : High-affinity IgE receptor-mediated stimulation of rat basophilic leukemia (RBL-2H3) cells induces early and late protein-tyrosine phosphorylations. J Biol Chem 1992 ; 267 : 7310-4.
25. Tkaczyk C, Gilfillan AM : Fc(epsilon)Ri-dependent signaling pathways in human mast cells. Clin Immunol 2001 ; 99 : 198-210.
26. al-Mohanna F, Parhar R, Kawaasi A, Ernst P, Sheth K, Harfi H, al-Sedairy S : Inhibition of neutrophil functions by human immunoglobulin E. J Allergy Clin Immunol 1993 ; 92 : 757-66.
27. Kepley CL, Youssef L, Andrews RP, Wilson BS, Oliver JM : Multiple defects in Fc epsilon RI signaling in Syk-deficient nonreleaser basophils and IL-3-induced recovery of Syk expression and secretion. J Immunol 2000 ; 165 : 5913-20.
28. Benhamou M, Siraganian RP : Protein-tyrosine phosphorylation: an essential component of Fc epsilon RI signaling. Immunol Today 1992 ; 13 : 195-7.
29. Bayon Y, Alonso A, Sanchez Crespo M : Immunoglobulin-E/dinitrophenyl complexes induce nitric oxide synthesis in rat peritoneal macrophages by a mechanism involving CD23 and NF-kappa B activation. Biochem Biophys Res Commun 1998 ; 242 : 570-4.
30. Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV: Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 1996 ; 379 : 346-9.
31. Daeron M : Negative regulation of mast cell activation by receptors for IgG. Int Arch Allergy Immunol 1997 ; 113 : 138-41.
32. Kepley CL, Cambier JC, Morel PA, Lujan D, Ortega E, Wilson BS, Oliver JM : Negative regulation of FcepsilonRI signaling by FcgammaRII costimulation in human blood basophils. J Allergy Clin Immunol 2000 ; 106 : 337-48.
33. Daeron M, Malbec O, Latour S, Arock M, Fridman WH : Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest 1995 ; 95 : 577-85.
34. Daeron M, Malbec O, Latour S, Espinosa E, Pina P, Fridman WH : Regulation of tyrosine-containing activation motif-dependent cell signalling by Fc gamma RII. Immunol Lett 1995 ; 44 : 119-23.
35. Daeron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S, Fridman WH : The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 1995 ; 3 : 635-46.
36. Malbec O, Attal JP, Fridman WH, Daeron M : Negative regulation of mast cell proliferation by FcgammaRIIB. Mol Immunol 2002 ; 38 : 1295-9.
37. Bieber T, de la Salle H, de la Salle C, Hanau D, Wollenberg A : Expression of the high-affinity receptor for IgE (Fc epsilon RI) on human Langerhans cells: the end of a dogma. J Invest Dermatol 1992 ; 99 : 10S-11S.
38. Bieber T, de la Salle H, Wollenberg A, Hakimi J, Chizzonite R, Ring J, Hanau D, de la Salle C : Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J Exp Med 1992 ; 175 : 1285-90.
39. Jurgens M, Wollenberg A, Hanau D, de la Salle H, Bieber T: Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE, Fc epsilon RI. J Immunol 1995 ; 155 : 5184-9.
40. Maurer D, Fiebiger S, Ebner C, Reininger B, Fischer GF, Wichlas S, Jouvin MH, Schmitt-Egenolf M, Kraft D, Kinet JP, Stingl G : Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha- and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation. J Immunol 1996 ; 157 : 607-16.
41. Magnan A, Vervloet D : Allergies : déterminants de la polarisation Th2 et mécanismes de la désensibilisation. Rev Mal Respir 1997 ; 14 : 173-81.
42. Szabo SJ, Dighe AS, Gubler U, Murphy KM : Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 1997 ; 185 : 817-24.
43. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky DH, Gubler U, Sinigaglia F: Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 1997 ; 185 : 825-31.
44. Mamessier E, Botturi K, Vervloet D, Magnan A : Lymphocytes T régulateurs, atopie et asthme : un nouveau concept en trois dimensions. Rev Mal Respir 2005 ; 22 : 305-11.
45. Okayama Y, Petit-Frere C, Kassel O, Semper A, Quint D, Tunon-de-Lara MJ, Bradding P, Holgate ST, Church MK : IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. J Immunol 1995 ; 155 : 1796-808.
46. Schroeder JT, MacGlashan DW Jr, Kagey-Sobotka A, White JM, Lichtenstein LM : IgE-dependent IL-4 secretion by human basophils. The relationship between cytokine production and histamine release in mixed leukocyte cultures. J Immunol 1994 ; 153 : 1808-17.
47. Spinozzi F, Agea E, Bistoni O, Forenza N, Bertotto A : gamma delta T cells, allergen recognition and airway inflammation. Immunol Today 1998 ; 19 : 22-6.
48. Godfrey DI, Kronenberg M : Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 2004 ; 114 : 1379-88.
49. Sallusto F, Mackay CR, Lanzavecchia A : Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997 ; 277 : 2005-7.
50. Kaplan MH, Schindler U, Smiley ST, Grusby MJ : Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 1996 ; 4 : 313-9.
51. Takeda K, Kamanaka M, Tanaka T, Kishimoto T, Akira S : Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J Immunol 1996 ; 157 : 3220-2.
52. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S : Essential role of Stat6 in IL-4 signalling. Nature 1996 ; 380 : 627-30.
53. Gause WC, Halvorson MJ, Lu P, Greenwald R, Linsley P, Urban JF, Finkelman FD : The function of costimulatory molecules and the development of IL-4-producing T cells. Immunol Today 1997 ; 18 : 115-20.
54. Kennedy MK, Picha KS, Fanslow WC, Grabstein KH, Alderson MR, Clifford KN, Chin WA, Mohler KM : CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur J Immunol 1996 ; 26 : 370-8.
55. Noelle RJ : CD40 and its ligand in host defense. Immunity 1996 ; 4 : 415-9.
56. Hofer MF, Jirapongsananuruk O, Trumble AE, Leung DY: Upregulation of B7.2, but not B7.1, on B cells from patients with allergic asthma. J Allergy Clin Immunol 1998 ; 101 : 96-102.
57. Gonzalo JA, Tian J, Delaney T, Corcoran J, Rottman JB, Lora J, Al-garawi A, Kroczek R, Gutierrez-Ramos JC, Coyle AJ : ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses. Nat Immunol 2001 ; 2 : 597-604.
58. Von Bubnoff D, Fimmers R, Bogdanow M, Matz H, Koch S, Bieber T : Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure. Clin Exp Allergy 2004 ; 34 : 1056-63.
59. 2 on bronchial responsiveness to histamine in normal subjects. Thorax 1989 ; 44 : 491-5.
60. Ben-Jebria A, Marthan R, Rossetti M, Savineau JP : Effect of passive sensitization on the mechanical activity of human isolated bronchial smooth muscle induced by substance P, neurokinin A and VIP. Br J Pharmacol 1993 ; 109 : 131-6.
61. Tunon de Lara JM, Okayama Y, Savineau JP, Marthan R : IgE-induced passive sensitization of human isolated bronchi and lung mast cells. Eur Respir J 1995 ; 8 : 1861-5.
62. Berger P, Walls AF, Marthan R, Tunon-de-Lara JM : Immunoglobulin E-induced passive sensitization of human airways: an immunohistochemical study. Am J Respir Crit Care Med 1998 ; 157 : 610-6.
63. Berger P, N'Guyen C, Buckley M, Scotto-Gomez E, Marthan R, Tunon-de-Lara JM : Passive sensitization of human airways induces mast cell degranulation and release of tryptase. Allergy 2002 ; 57 : 592-9.
64. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID : Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002 ; 346 : 1699-705.
65. Hakonarson H, Carter C, Kim C, Grunstein MM : Altered expression and action of the low-affinity IgE receptor FcepsilonRII (CD23) in asthmatic airway smooth muscle. J Allergy Clin Immunol 1999 ; 104 : 575-84.
66. Hakonarson H, Grunstein MM. Autologously up-regulated Fc receptor expression and action in airway smooth muscle mediates its altered responsiveness in the atopic asthmatic sensitized state. Proc Natl Acad Sci U S A 1998 ; 95 : 5257-62.
67. Bentley AM, Menz G, Storz C, Robinson DS, Bradley B, Jeffery PK, Durham SR, Kay AB : Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis 1992 ; 146 : 500-6.
68. Humbert M, Grant JA, Taborda-Barata L, Durham SR, Pfister R, Menz G, Barkans J, Ying S, Kay AB : High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med 1996 ; 153 : 1931-7.
69. Pirson F, Charpin D, Sansonetti M, Lanteaume A, Kulling G, Charpin J, Vervloet D : Is intrinsic asthma a hereditary disease? Allergy 1991 ; 46 : 367-71.
70. Humbert M, Durham SR, Ying S, Kimmitt P, Barkans J, Assoufi B, Pfister R, Menz G, Robinson DS, Kay AB, Corrigan CJ : IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 1996 ; 154 : 1497-504.
71. Ying S, Humbert M, Barkans J, Corrigan CJ, Pfister R, Menz G, Larche M, Robinson DS, Durham SR, Kay AB : Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1997 ; 158 : 3539-44.
72. Humbert M, Durham SR, Kimmitt P, Powell N, Assoufi B, Pfister R, Menz G, Kay AB, Corrigan CJ : Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol 1997 ; 99 : 657-65.
73. Humbert M, Robinson DS, Assoufi B, Kay AB, Durham SR : Safety of fibreoptic bronchoscopy in asthmatic and control subjects and effect on asthma control over two weeks. Thorax 1996 ; 51 : 664-9.
74. Bernstein IL, Storms WW : Practice parameters for allergy diagnostic testing. Joint Task Force on Practice Parameters for the Diagnosis and Treatment of Asthma.The American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1995 ; 75 : 543-625.
75. Demoly P, Bousquet J, Manderscheid JC, Dreborg S, Dhivert H, Michel FB : Precision of skin prick and puncture tests with nine methods. J Allergy Clin Immunol 1991 ; 88 : 758-62.
76. Burney PG, Luczynska C, Chinn S, Jarvis D : The European Community Respiratory Health Survey. Eur Respir J 1994 ; 7 : 954-60.
77. Burney P, Malmberg E, Chinn S, Jarvis D, Luczynska C, Lai E : The distribution of total and specific serum IgE in the European Community Respiratory Health Survey. J Allergy Clin Immunol 1997 ; 99 : 314-22.
78. Survey ECRH : Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996 ; 9 : 687-95.
79. Sunyer J, Anto JM, Sabria J, Roca J, Morell F, Rodriguez-Roisin R, Rodrigo MJ : Relationship between serum IgE and airway responsiveness in adults with asthma. J Allergy Clin Immunol 1995 ; 95 : 699-706.
80. Sears MR, Burrows B, Flannery EM, Herbison GP, Hewitt CJ, Holdaway MD : Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N Engl J Med 1991 ; 325 : 1067-71.
81. Peat JK, Toelle BG, Dermand J, Van den Berg R, Britton WJ, Woolcock AJ : Serum IgE levels, atopy, and asthma in young adults: results from a longitudinal cohort study. Allergy 1996 ; 51 : 804-10.
82. Annesi I, Oryszczyn MP, Frette C, Neukirch F, Orvoen-Frija E, Kauffmann F : Total circulating IgE and FEV1 in adult men. An epidemiologic longitudinal study. Chest 1992 ; 101 : 642-8.
83. Tracey M, Villar A, Dow L, Coggon D, Lampe FC, Holgate ST : The influence of increased bronchial responsiveness, atopy, and serum IgE on decline in FEV1. A longitudinal study in the elderly. Am J Respir Crit Care Med 1995 ; 151 : 656-62.
84. Annesi I, Oryszczyn MP, Neukirch F, Orvoen-Frija E, Korobaeff M, Kauffmann F : Relationship of upper airways disorders to FEV1 and bronchial hyperresponsiveness in an epidemiological study. Eur Respir J 1992; 5 : 1104-10.
85. Burrows B, Knudson RJ, Cline MG, Lebowitz MD : A reexamination of risk factors for ventilatory impairment. Am Rev Respir Dis 1988 ; 138 : 829-36.
86. Omenaas E, Bakke P, Eide GE, Elsayed S, Gulsvik A : Serum house dust mite antibodies: predictor of increased bronchial responsiveness in adults of a community. Eur Respir J 1996 ; 9 : 919-25.
87. Ferrante E, Corbo GM, Valente S, Ciappi G : Associations between atopy, asthma history, respiratory function and non-specific bronchial hyperresponsiveness in unselected young asthmatics. Respiration 1992 ; 59 : 169-72.
88. Takeda K, Shibasaki M, Takita H : Relation between bronchial responsiveness to methacholine and levels of IgE antibody against Dermatophagoides farinae and serum IgE in asthmatic children. Clin Exp Allergy 1993 ; 23 : 450-4.
89. Gerrard JW, Heiner DC, Ko CG, Mink J, Meyers A, Dosman JA : Immunoglobulin levels in smokers and non-smokers. Ann Allergy 1980 ; 44 : 261-2.
90. Zetterstrom O, Johansson SG : IgE concentrations measured by PRIST in serum of healthy adults and in patients with respiratory allergy. A diagnostic approach. Allergy 1981 ; 36 : 537-47.
91. Kulig M, Luck W, Lau S, Niggemann B, Bergmann R, Klettke U, Guggenmoos-Holzmann I, Wahn U : Effect of pre- and postnatal tobacco smoke exposure on specific sensitization to food and inhalant allergens during the first 3 years of life. Multicenter Allergy Study Group, Germany. Allergy 1999 ; 54 : 220-8.
92. Omenaas E, Bakke P, Elsayed S, Hanoa R, Gulsvik A : Total and specific serum IgE levels in adults: relationship to sex, age and environmental factors. Clin Exp Allergy 1994 ; 24 : 530-9.
93. Jarvis D, Luczynska C, Chinn S, Burney P : The association of age, gender and smoking with total IgE and specific IgE. Clin Exp Allergy 1995 ; 25 : 1083-91.
94. Nadel JA, Comroe JH Jr : Acute effects of inhalation of cigarette smoke on airway conductance. J Appl Physiol 1961 ; 16 : 713-6.
95. Strachan DP, Butland BK, Anderson HR : Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort. BMJ 1996 ; 312 : 1195-9.
96. Lundback B : Epidemiology of rhinitis and asthma. Clin Exp Allergy 1998 ; 28 (Suppl 2) : 3-10.
97. Vesterinen E, Kaprio J, Koskenvuo M : Prospective study of asthma in relation to smoking habits among 14,729 adults. Thorax 1988 ; 43 : 534-9.
98. Magnusson CG : Maternal smoking influences cord serum IgE and IgD levels and increases the risk for subsequent infant allergy. J Allergy Clin Immunol 1986 ; 78 : 898-904.
99. Soyseth V, Kongerud J, Boe J : Postnatal maternal smoking increases the prevalence of asthma but not of bronchial hyperresponsiveness or atopy in their children. Chest 1995 ; 107 : 389-94.
100. Strachan DP, Cook DG : Health effects of passive smoking .5. Parental smoking and allergic sensitisation in children. Thorax 1998 ; 53 : 117-23.
101. Colley JR, Holland WW, Corkhill RT : Influence of passive smoking and parental phlegm on pneumonia and bronchitis in early childhood. Lancet 1974 ; 2 : 1031-4.
102. Strachan DP, Cook DG : Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax 1997 ; 52 : 905-14.
103. Fergusson DM, Horwood LJ, Shannon FT, Taylor B : Parental smoking and lower respiratory illness in the first three years of life. J Epidemiol Community Health 1981 ; 35 : 180-4.
104. Tariq SM, Hakim EA, Matthews SM, Arshad SH : Influence of smoking on asthmatic symptoms and allergen sensitisation in early childhood. Postgrad Med J 2000 ; 76 : 694-9.
105. Huss K, Adkinson NF, Jr., Eggleston PA, Dawson C, Van Natta ML, Hamilton RG : House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program. J Allergy Clin Immunol 2001 ; 107 : 48-54.
106. Kuehr J, Frischer T, Meinert R, Barth R, Forster J, Schraub S, Urbanek R, Karmaus W : Mite allergen exposure is a risk for the incidence of specific sensitization. J Allergy Clin Immunol 1994 ; 94 : 44-52.
107. Lau S, Illi S, Sommerfeld C, Niggemann B, Bergmann R, von Mutius E, Wahn U : Early exposure to house-dust mite and cat allergens and development of childhood asthma: a cohort study. Multicentre Allergy Study Group. Lancet 2000 ; 356 : 1392-7.
108. Sporik R, Squillace SP, Ingram JM, Rakes G, Honsinger RW, Platts-Mills TA : Mite, cat, and cockroach exposure, allergen sensitisation, and asthma in children: a case-control study of three schools. Thorax 1999 ; 54 : 675-80.
109. Munir AK, Einarsson R, Schou C, Dreborg SK : Allergens in school dust. I. The amount of the major cat (Fel d I) and dog (Can f I) allergens in dust from Swedish schools is high enough to probably cause perennial symptoms in most children with asthma who are sensitized to cat and dog. J Allergy Clin Immunol 1993 ; 91 : 1067-74.
110. Wahn U, Lau S, Bergmann R, Kulig M, Forster J, Bergmann K, Bauer CP, Guggenmoos-Holzmann I : Indoor allergen exposure is a risk factor for sensitization during the first three years of life. J Allergy Clin Immunol 1997 ; 99 : 763-9.
111. Vervloet D, Penaud A, Razzouk H, Senft M, Arnaud A, Boutin C, Charpin J : Altitude and house dust mites. J Allergy Clin Immunol 1982 ; 69 : 290-6.
112. Peroni DG, Boner AL, Vallone G, Antolini I, Warner JO : Effective allergen avoidance at high altitude reduces allergen-induced bronchial hyperresponsiveness. Am J Respir Crit Care Med 1994 ; 149 : 1442-6.
113. Eggleston PA, Rosenstreich D, Lynn H, Gergen P, Baker D, Kattan M, Mortimer KM, Mitchell H, Ownby D, Slavin R, Malveaux F : Relationship of indoor allergen exposure to skin test sensitivity in inner-city children with asthma. J Allergy Clin Immunol 1998 ; 102 : 563-70.
114. Platts-Mills T, Vaughan J, Squillace S, Woodfolk J, Sporik R : Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet 2001 ; 357 : 752-6.
115. Ronmark E, Perzanowski M, Platts-Mills T, Lundback B : Four-year incidence of allergic sensitization among schoolchildren in a community where allergy to cat and dog dominates sensitization: report from the Obstructive Lung Disease in Northern Sweden Study Group. J Allergy Clin Immunol 2003 ; 112 : 747-54.
116. Jarvis D, Chinn S, Luczynska C, Burney P : The association of smoking with sensitization to common environmental allergens: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999 ; 104 : 934-40.
117. Garrett MH, Hooper MA, Hooper BM, Rayment PR, Abramson MJ : Increased risk of allergy in children due to formaldehyde exposure in homes. Allergy 1999 ; 54 : 330-7.
118. Lindfors A, van Hage-Hamsten M, Rietz H, Wickman M, Nordvall SL : Influence of interaction of environmental risk factors and sensitization in young asthmatic children. J Allergy Clin Immunol 1999 ; 104 : 755-62.
119. Altounyan R : Changes in histamine and atropine responsiveness as a guide to diagnosis and evaluation of therapy in obstructive airways disease. Pepys J, Frankland AW editors : Disodium cromoglycate in allergic airways disease London, 1969, Butterworth & Co. Ltd; 47-53.
120. Cockcroft DW, Ruffin RE, Dolovich J, Hargreave FE : Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy 1977 ; 7 : 503-13.
121. Sears MR, Herbison GP, Holdaway MD, Hewitt CJ, Flannery EM, Silva PA : The relative risks of sensitivity to grass pollen, house dust mite and cat dander in the development of childhood asthma. Clin Exp Allergy 1989 ; 19 : 419-24.
122. Reid MJ, Moss RB, Hsu YP, Kwasnicki JM, Commerford TM, Nelson BL : Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy. J Allergy Clin Immunol 1986 ; 78 : 590-600.
123. O'Hollaren MT, Yunginger JW, Offord KP, Somers MJ, O'Connell EJ, Ballard DJ, Sachs MI : Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991 ; 324 : 359-63.
124. Call RS, Smith TF, Morris E, Chapman MD, Platts-Mills TA : Risk factors for asthma in inner city children. J Pediatr 1992 ; 121 : 862-6.
125. Gelber LE, Seltzer LH, Bouzoukis JK, Pollart SM, Chapman MD, Platts-Mills TA : Sensitization and exposure to indoor allergens as risk factors for asthma among patients presenting to hospital. Am Rev Respir Dis 1993 ; 147 : 573-8.
126. Sporik R, Ingram JM, Price W, Sussman JH, Honsinger RW, Platts-Mills TA : Association of asthma with serum IgE and skin test reactivity to allergens among children living at high altitude. Tickling the dragon's breath. Am J Respir Crit Care Med 1995 ; 151 : 1388-92.
127. de Blay F : Airborne characteristics of indoor allergens : relevance to disease and avoidance. Eur Respir Rev 1998 ; 8 : 148-52.
128. Platts-Mills TA, Tovey ER, Mitchell EB, Moszoro H, Nock P, Wilkins SR : Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet 1982 ; 2 : 675-8.
129. Boner AL, Niero E, Antolini I, Valletta EA, Gaburro D : Pulmonary function and bronchial hyperreactivity in asthmatic children with house dust mite allergy during prolonged stay in the Italian Alps (Misurina, 1756 m). Ann Allergy 1985 ; 54 : 42-5.
130. Hesselmar B, Aberg N, Aberg B, Eriksson B, Bjorksten B : Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy 1999 ; 29 : 611-7.
131. Roost HP, Kunzli N, Schindler C, Jarvis D, Chinn S, Perruchoud AP, Ackermann-Liebrich U, Burney P, Wuthrich B : Role of current and childhood exposure to cat and atopic sensitization. European Community Respiratory Health Survey. J Allergy Clin Immunol 1999 ; 104 : 941-7.
132. McCarthy DS, Pepys J : Allergic broncho-pulmonary aspergillosis. Clinical immunology. 2. Skin, nasal and bronchial tests. Clin Allergy 1971 ; 1 : 415-32.
133. Greenberger PA : Allergic bronchopulmonary aspergillosis and fungoses. Clin Chest Med 1988 ; 9 : 599-608.
134. Greenberger PA : Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002 ; 110 : 685-92.
135. Wark PA, Hensley MJ, Saltos N, Boyle MJ, Toneguzzi RC, Epid GD, Simpson JL, McElduff P, Gibson PG : Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003 ; 111 : 952-7.
136. Greenberger PA, Smith LJ, Hsu CC, Roberts M, Liotta JL : Analysis of bronchoalveolar lavage in allergic bronchopulmonary aspergillosis: divergent responses of antigen-specific antibodies and total IgE. J Allergy Clin Immunol 1988 ; 82 : 164-70.
137. Milgrom H, Fick RB Jr., Su JQ, Reimann JD, Bush RK, Watrous ML, Metzger WJ : Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. N Engl J Med 1999 ; 341 : 1966-73.
138. Soler M, Matz J, Townley R, Buhl R, O'Brien J, Fox H, Thirlwell J, Gupta N, Della Cioppa G : The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J 2001 ; 18 : 254-61.
139. Humbert M, Beasley R, Ayres J, Slavin R, Hebert J, Bousquet J, Beeh KM, Ramos S, Canonica GW, Hedgecock S, Fox H, Blogg M, Surrey K : Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 2005 ; 60 : 309-16.